Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-12-01T02:02:06.621Z Has data issue: false hasContentIssue false
  • English
  • Français

Methicillin-Resistant Staphylococcus aureus: Clinical and Laboratory Features

Published online by Cambridge University Press:  02 January 2015

Kenneth E. Aldridge
Kenneth E. Aldridge*
Affiliation:
Departments of Medicine, Pathology, and Obstetrics and Gynecology, Louisiana State University Medical Center, New Orleans, Louisiana
*
Pathology, Obstetrics and Gynecology, LSU Medical Center, New Orleans, LA 70112
Get access Rights & Permissions [Opens in a new window]

Extract

Not long after the introduction of penicillin G for anti-staphylococcal therapy, penicillin G resistant strains of staphylococci were isolated and were found to produce penicillinase enzymes. In 1959 methicillin, a penicillinase resistant penicillin (PRP), was introduced in England for therapy of these strains. Within 2 years the first strains of methicillin-resistant Staphylococcus aureus (MRSA) were reported in that country. Subsequently, reports of MRSA infections throughout Europe appeared. Reports from Switzerland and Denmark indicated that 30% to 50% of all nosocomial S. aureus isolates and 40% of all S. aureus bacteremia isolates, respectively, were due to MRSA. Although sporadic reports of MRSA infections appeared in the US after 1960 the first documented outbreak of MRSA infections occurred at Boston City Hospital in 1968. Even today there is not a complete understanding of MRSA and its role in infectious diseases, however, a vast amount of information has accumulated and certain aspects of this information will be discussed.

Type
Special Sections
Information
Infection Control & Hospital Epidemiology , Volume 6 , Issue 11 , November 1985 , pp. 461 - 465
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Editorial. A new penicillin. Br Med J 1960;2:720–721.CrossRefGoogle Scholar
2. Jevons, MP: “Celbenin”-resistant staphylococci. Br Med J 1961;1:124–125.Google Scholar
3. Kallings, LO: The susceptibility of staphylococcal hospital strains to methylphenyl-isoxazolyl penicillin. Acta Pathol Microbiol Immunol Scand 1962;54:127–128.Google Scholar
4. Jevons, MP, Coe, AW, Parker, MT: Methicillin-resistance in staphylococci. Lancet 1963;1:904–907.Google Scholar
5. Colley, EW, McNicol, MW, Bracken, PM: Methicillin-resistant staphylococci in a general hospital. Lancet 1965;1:595–597.CrossRefGoogle ScholarPubMed
6. Kayser, FH, Mak, TM: Methicillin-resistant staphylococci. Am J Med Sci 1972;264:197–205.Google Scholar
7. Jessen, O, Rosendal, K, Bulow, P, et al: Changing staphylococci and staphylococcal infections. N Engl J Med 1969;281:627–635.Google Scholar
8. Barrett, FF, McGehee, RF Jr Finland, M: Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med 1968;279:441–448.Google Scholar
9. Gravenkemper, CF, Brodie, JL, Kirby, WMM: Resistance of coagulase-positive staphylococci to methicillin and oxacillin. J Bacteriol 1965;89:1005–1010.Google Scholar
10. Bulger, RJ: A methicillin-resistant strain of Staphylococcus aureus. Clinical and laboratory experience. Ann Intern Med 1967;67:81–89.Google Scholar
11. Seligman, SJ: Resistant Staphylococcus aureus . N Engl J Med 1967;277:1267–1268.Google Scholar
12. Boyce, JM, Causey, WA: Increasing occurrence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control 1982;3:377–383.Google Scholar
13. Center for Disease Control: Methicillin resistant Staphylococcus aureus—United States. MMWR 1981;557–559.Google Scholar
14. Haley, RW, Hightower, AW, Khabbaz, RF: The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann Intern Med 1982;97:297–308.CrossRefGoogle ScholarPubMed
15. Thompson, RL, Cabezudo, I, Wenzel, RP: Epidemiology of nosocomial infections caused by methicillin-resistant S. aureus . Ann Intern Med 1982;97:309–317.Google Scholar
16. Peacock, JE, Marsik, FJ, Wenzel, RP: Methicillin-resistant Staphylococcus aureus: Introduction and spread within a hospital. Ann Intern Med 1980;93:526–532.CrossRefGoogle ScholarPubMed
17. Price, EH, Brain, A, Dickson, JAS: An outbreak of infection with a gentamicin and methicillin-resistant Staphylococcus aureus in a neonatal unit. J Hosp Infect 1980;1:221–228.Google Scholar
18. Dunkle, LM, Naqvi, SH, McCallum, R, et al: Eradication of epidemic methicillin-gentamicin-resistant Staphylococcus aureus in an intensive care nursery. Am J Med 1981;70:455–458.Google Scholar
19. Weinstein, RA, Kabins, SA: Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med 1981;70:449–454.Google Scholar
20. Boyce, JM: Nosocomial staphylococcal infections. Ann Intern Med 1981;95:241–242.Google Scholar
21. Saravolatz, LD, Pohlod, DJ, Arking, LM: Community-acquired methicillin-resistant Staphylococcus aureus infections: A new source for nosocomial outbreaks. Ann Intern Med 1982;97:325–329.Google Scholar
22. Levine, DP, Cushing, RD, Jui, J, et al: Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med 1982;97:330–338.CrossRefGoogle ScholarPubMed
23. Freeman, BA (ed): The Staphylococci, in Burrows Textbook of Microbiology, ed 21. Philadelphia, WB Saunders Co., 1979; pp 429–446.Google Scholar
24. Peacock, JE Jr Moormar, DR, Wenzel, RP, et al: Methicillin-resistant Staphylococcus aureus: Microbiologic characteristics, antibiotic susceptibilities and assessment of virulence of an epidemic strain. J Infect Dis 1981;144:575–582.Google Scholar
25. Vernon, GN, Russell, AD: Surface properties of cells of some methicillin-resistant strains of Staphylococcus aureus . J Antibiot 1977;30:974–979.Google Scholar
26. Sabath, L: Chemical and physical factors influencing methicillin resistance of Staphylococcus aureus and Staphylococcus epidermidis . J Antimicrob Chemother 1977;3:47–51.Google Scholar
27. Canawati, HN, Witte, JL, Sapico, FL: Temperature effect on the susceptibility of methicillin-resistant Staphylococcus aureus to four different cephalosporins. Antimicrob Agents Chemother 1982;21:173–175.Google Scholar
28. Hartman, B, Tomasz, A: Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureus . Antimicrob Agents Chemother 1981;19:726–735.Google Scholar
29. Smith, PF, Wilkinson, BJ: Differential methicillin susceptibilities of peptidoglycan syntheses in methicillin-resistant Staphylococcus aureus. 1981;148:610–617.Google Scholar
30. Rossi, L, Tonin, E, Cheng, YR, et al: Regulation of penicillin-binding protein activity: Description of a methicillin-inducible penicillin-binding protein in Staphylococcus aureus . Antimicrob Agents Chemother 1985;27:828–831.CrossRefGoogle ScholarPubMed
31. Ubukata, K, Yamashita, N, Konno, M: Occurrence of a β-lactam inducible penicillin-binding protein in methicillin-resistant staphylococci. Antimicrob Agents Chemother 1985;27:851–857.Google Scholar
32. Cohen, S, Sweeney, HM: Effect of the prophage and penicillinase plasmid of the recipient strain upon the transduction and the stability of methicillin resistance in Staphylococcus aureus . J Bacteriol 1973;116:803–811.Google Scholar
33. Kayser, FH, Wust, J, Corrodi, P: Transduction and elimination of resistance determinants in methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother 1972;2:217–223.Google Scholar
34. Townsend, DE, Grubb, WB, Ashdown, N: Genetics of drug resistance in methicillin-resistant Staphylococcus aureus from Australian hospitals. J Hosp Infect 1983;4:331–337.Google Scholar
35. Barry, AL, Badal, RE: Reliability of the microdilution technic for detection of methicillin-resistant strains of Staphylococcus aureus . Am J Clin Pathol 1977;67:489–495.Google Scholar
36. Cleary, TJ, Maurer, D: Methicillin-resistant Staphylococcus aureus susceptibility testing by an automated system, Autobac I. Antimicrob Agents Chemother 1978;13:837–841.CrossRefGoogle ScholarPubMed
37. Boyce, JM, White, RL, Bonner, MC, et al: Reliability of the MS-2 system in detecting methicillin-resistant Staphylococcus aureus . J Clin Microbiol 1982;15:220–225.Google Scholar
38. Blair, HC, Cleary, TJ: Susceptibility testing of multidrug-resistant Staphylococcus aureus with the Sceptor microdilution system. J Clin Microbiol 1983;18:194–196.Google Scholar
39. Lindsey, NJ, Barnes, WG: Examination of major disagreements in susceptibility test results by Autobac-1 and MS-2. Antimicrob Agents Chemother 1981;20:115–119.CrossRefGoogle ScholarPubMed
40. Aldridge, KE, Janney, A, Sanders, CV, et al: Interlaboratory variation of antibiograms of methicillin-resistant and methicillin-susceptible Staphylococus aureus strains with conventional and commercial testing systems. J Clin Microbiol 1983;18:1226–1236.CrossRefGoogle Scholar
41. Thornsberry, C: Methicillin-resistant (heteroresistant) staphylococci. Antimicrob Newsletter 1984;1:43–47.Google Scholar
42. Thornsberry, C, McDougal, LK: Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci. J Clin Microbiol 1983;18:1084–1091.Google Scholar
43. National Committee for Clinical Laboratory Standards: Tentative standard M7-T Standard methods for dilution antimicrobial tests for bacteria which grow aerobically. National Committee for Clinical Laboratory Standards, Villanova, PA, 1983.Google Scholar
44. McDougal, LK, Thornsberry, C: New recommendations for disk diffusion antimicrobial susceptibility tests for methicillin-resistant (heteroresistant) staphylococci. J Clin Microbiol 1984;19:482–488.Google Scholar
45. Neu, HC: Treatment of methicillin-resistant Staphylococcus infections. 1984;1:47–48.Google Scholar
46. Watanakunakorn, C: Treatment of infections due to methicillin-resistant Staphylococcus aureus. 1982;97:376–378.Google Scholar
47. Watanakunakorn, C, Guerriero, JC: Interaction beween vancomycin and rifampin against Staphylococcus aureus . Antimicrob Agents Chemother 1981;19:1089–1091.CrossRefGoogle Scholar
48. Acar, JF, Courvalin, P, Chabbert, YA: Methicillin-resistant staphylococcemia: Bacteriological failure of treatment with cephalosporins. Antimicrob Agents Chemother—1970. Bethesda, Maryland: American Society for Microbiology 1971;280–285.Google Scholar
49. Coppens, L, Hanson, B, Klastersky, J: Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin. Antimicrob Agents Chemother 1983;23:36–41.Google Scholar
50. Tuazon, CU, Lin, MYC, Sheagren, JN: In vitro activity of rifampin alone and in combination with nafcillin and vancomycin against pathogenic strains of Staphylococcus aureus . Antimicrob Agents Chemother 1978;13:759–761.CrossRefGoogle ScholarPubMed
51. Bayer, AS, Morrison, JO: Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus . Antimicrob Agents Chemother 1984;26:220–223.CrossRefGoogle ScholarPubMed
52. Bayer, AS, Lam, K: Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus : In vitro-in vivo correlations. Infect Dis 1985;151:157–165.Google Scholar
53. Eng, RHK, Smith, SM, Tillem, M, et al: Rifampin resistance. Development during the therapy of methicillin-resistant Staphylococcus aureus infection. Arch Intern Med 1985;145:146–148.Google Scholar
54. Markowitz, N, Saravolatz, L, Pohlod, D, et al: Comparative efficacy and toxicity of trimethoprim-sulfamethoxazole versus vancomycin in the treatment of serious S. aureus infections. Presented at the 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Las Vegas, Nevada, 1983.Google Scholar
55. Winn, RE, Ward, TT, Hartstein, AI, et al: Epidemiological, bacteriological, and clinical observations on an interhospital outbreak of nafcillin-resistant Staphylococcus aureus . Current Chemotherapy 1979;2:1096–1097.Google Scholar
56. Aldridge, KE, Schiro, DD, Tsai, L, et al: Ciprofloxacin (BAY o9867): An in vitro comparison with other broad spectrum antibiotics. Current Therapeutic Research 1985;35:754–762.Google Scholar
57. Neu, HC, Labthavikul, P: In vitro activity of teichomycin compared with those of other antibiotics. Antimicrob Agents Chemother 1983;24:425–428.CrossRefGoogle ScholarPubMed
58. Neu, HC, Chin, NX, Labthavikul, P: Antibacterial activity of coumermycin alone and in combination with other antibiotics. Antimicrob Agents Chemother 1984;25:687–689.CrossRefGoogle ScholarPubMed
59. Pallanza, R, Berti, M, Goldstein, BP, et al: Teichomycin: In vitro and in vivo evaluation in comparison with other antibiotics. J Antimicrob Chemother 1983;11:417–425.Google Scholar
60. Smith, SM, Eng, RHK: Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother 1985;27:688–691.Google Scholar